General Qureight publishes in the European Respiratory Journal, calling for fibrosis burden to become the principal structural imaging biomarker for antifibrotic trialsBy Healthcare Propulsion StaffNovember 2, 20260 Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, today…
General Researchers call for coordinated action to protect European sleep healthBy Healthcare Propulsion StaffOctober 21, 20260 A new paper from the Equality, Diversity and Inclusion Committee and the Early Career Network of the European Sleep Research…
